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ABSTRACT 
Background: Despite the chronic and relapsing nature of inflammatory bowel diseases 
(IBD), at least 30 to 45% of the patients are non-compliant to treatment. IBD patients 
often seek information about their disease.  
Aim: To examine the association between information seeking activity and treatment 
compliance among IBD patients. To compare information sources and concerns 
between compliant and non- compliant patients 
Methods: We used data from the Swiss IBD cohort study, and from a qualitative survey 
conducted to assess information sources and concerns. Crude and adjusted odds ratios 
(OR) for non-compliance were calculated. Differences in the proportions of information 
sources and concerns were compared between compliant and non-compliant patients.  
Results: 512 patients were included. Eighteen percent (N=99) reported to be non- 
compliant to drug treatment and two thirds (N=353) were information seekers. The OR 
for non-compliance among information seekers was 2.39 (95%CI 1.32-4.34) after 
adjustment for confounders and major risk factors. General practitioners were 15.2% 
more often consulted (p=0.019) among compliant patients, as were books and TV 
(+13.1%; p=0.048) while no difference in proportions was observed for sources such as 
internet or gastroenterologists. Information on tips for disease management were 14.2% 
more often sought among non-compliant patients (p=0.028). No difference was 
observed for concerns on research and development on IBD or therapies.  
Conclusion: In Switzerland, IBD patients non-compliant to treatment were more often 
seeking disease-related information than compliant patients. Daily management of 
symptoms and disease seemed to be an important concern of those patients.  
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INTRODUCTION 
Inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and ulcerative 
colitis (UC) are mostly diagnosed at young age, implying a lifelong duration of disease 
with relapsing acute phases followed by periods of remission (1). Phases and their 
duration are not predictable, and their frequency, severity and treatment vary largely 
among patients, impacting on daily living and quality of life. Most patients require long-
term and multiple therapy regimens and about 70% of CD patients require respective 
bowel surgery. 
Despite the known risk of recurrence, 7 to 72% of IBD patients reported to be non-
adherent to treatments (2), with a mean varying between 30% and 45%, during 
maintenance of remission. Previous studies showed the proportion of adherent patients 
to be generally higher in CD as compared to UC (2-4), because of the need for more 
regular medical visits, with increased contact and communication. Risk factors for non-
adherence were of different types: socio-demographic, psychosocial, disease-related, 
information- or knowledge-related. Younger age, being male or single or having a full-
time daily activity were related to non- or low- adherence (2, 5-7); income or 
deprivation scores showed no association (5). Distress, anxiety, perceived stress and 
well-being showed conflicting results (5, 7, 8). Disease duration, location and activity as 
well as a recent diagnosis and infrequent visits to physician were related to non-
compliance (4, 9). In addition, drug-related factors such as type of drugs, burden of drug 
regimens, multiple therapies, and complicated dosage regimens increased the risk of 
forgetfulness (2, 4, 10). The first studies investigating IBD patient’s information needs 
in the 70’s to 90’s showed concerns focused on aetiology, symptoms, diet, and on 
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therapies and their related risks and benefits (11-15). Low information and support were 
associated with non-adherence to treatment (16, 17). Kane assumed that improving the 
information that physician may give to patients concerning drugs and their use would 
increase adherence (6). Beliefs about medications and doctor-patient discordance on 
beliefs were found to be associated with low adherence (2), but trust-in-physician was 
shown to be highly correlated with adherence (8). Carpenter observed, in a sample of 
chronically ill patients (18), that one half (51%) of them received conflicting 
information, a phenomenon requiring further investigation, including the distinction 
between active and passive ways of gathering information and its impact on treatment 
adherence.  
 
The effect of being well-informed on potential improvement of the course and 
management of IBD has been hypothesised, but not well explored. Adherence, which 
definition supposes there was a patient-physician agreement on the treatment 
recommendation (19) encloses compliance, defined more crudely as “the extent to 
which the patient’s behaviour matches the prescriber’s recommendations”. We aimed to 
investigate the role of patients’ information seeking activities on treatment compliance. 
A secondary objective was to explore and compare sources and themes of information 
sought by patients with respect to being compliant or non- compliant to treatment. 
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MATERIALS AND METHODS 
Study design and population 
This cross-sectional study used data from patients included in the Swiss Inflammatory 
Bowel Diseases Cohort (SIBDC), a national clinical cohort launched in November 
2006. The methods and goals of the study were described elsewhere (20). Briefly, the 
study enrolled paediatric or adult patients with CD, UC or indeterminate colitis, with a 
diagnosis having been established for at least four months and confirmed by 
radiological, endoscopic or surgery assessment. Patients with other forms of colitis, 
having no permanent residence in Switzerland, or refusing to sign the informed consent 
form were excluded. Patients were enrolled by their treating gastroenterologist in 
private or public ambulatory practices and hospitals. The study population consisted of 
all adult patients included in the cohort study between November 2006 and August 
2009, taking at least one drug at baseline, and who responded to a survey on 
information seeking.  
Data collection and management 
Clinical data were gathered from gastroenterologists or study nurses through clinical 
reporting forms during the enrolment medical visit. A self-administered questionnaire 
was sent to patients by mail following the baseline medical visit. A qualitative survey 
was developed based on critical incident reporting method (21, 22), and was conducted 
in October 2009 among patients enrolled up to that time to investigate sources and 
themes of information searched in four critical stages of the disease. Linkage with 
SIBDC clinical and patient data was made by using the unique ID number, assigned to 
all patients included in the cohort.  
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Outcome and exposures 
The studied outcome was “non-compliance to treatment”. This measure was study-
specifically developed and collected as an unordered categorical variable with 5 
categories for each drug therapy taken by the patient. The categories were: “therapy 
taken according to dosage and frequency prescribed”, “therapy taken according to 
dosage but not always to the frequency”, “therapy taken according to frequency but no 
always to the dosage”, “therapy taken according neither to dosage nor to the frequency”, 
“therapy never taken”. For the purpose of this study compliance was treated as a binary 
variable; “compliant” referred to complete respect of dosage and frequency and “non-
compliant” to any of the 4 other categories. 
Information seeking was studied for two main disease stages, i.e., activity or remission. 
To investigate the overall association between compliance and information seeking, we 
first defined exposure as a binary variable (yes/no); “yes” referred to information 
seeking, whether at the time of disease activity, or of remission, and “no” to no 
information seeking. Patients were considered as active information seekers if they had 
sought information in at least one of the two disease stages. For the purpose of this 
study, we classified patients who did not remember if they sought information (N=6) as 
non-seekers. Themes of information searched were collected as follows: patients were 
first asked to check if they had sought information (“yes”, “no”, “do not remember”), 
then they were asked to describe the type of information sought through an open-ended 
question. Content analysis was performed by extracting keywords out of the text from 
open-ended questions and by grouping them, first in sub-themes then in main themes. A 
double check of the classifications in sub- and main themes was performed 
independently by an experienced qualitative researcher. The number of sub- themes 
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defined was 43, which were grouped in 6 main information themes (Table 1). Each 
patient could seek information in a single or in multiple themes. To explore the 
proportion of each theme explored independently we created 6 binary variables, each 
referring to one of the main themes. Sources patients may have used to gather 
information on their disease were identified using a pre-established list of six binary 
variables: “family doctor”, “gastroenterologist”, “pharmacist”, “patient association”, 
“internet”, “book” or “TV”. 
Potential confounders and other risk factors 
Potential confounding for the association between compliance and information seeking 
was explored for the following variables: age, gender, duration of disease, marital 
status, education level, working status, depression and anxiety scores (23), type of 
diagnosis, previous surgeries, previous complications, use of alternative medicine, use 
of nutritional supplements, type of drugs and poly-medication. Marital status was 
considered as a binary variable, with two categories: “legally married” / “not married”. 
Education level was grouped into 3 categories: “Primary (mandatory) education level”, 
“Secondary education level”, and “university level and assimilated”. Working status 
was grouped into 6 categories: “full-time activity”, “part-time activity”, “unemployed”, 
“in training”, “at home”, and “retired”. Both education and working status 
classifications derived from these commonly used in the Swiss national health statistics 
(http://www.bfs.admin.ch/). Drug therapies were treated using two distinct variables: 
type of drug regimen and number of concomitant drugs. Types of drug regimens were 
classified taking account of the burden they might place on patients, e.g. potential 
adverse effects and their severity, burden induced by administration route (topical, oral 
or intravenous), and for this reason were grouped into the following categories: 
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“Antibiotics or topical steroids” (metronidazole, ciprofloxacin, topical steroids, 
budesonide), “5-ASA” (oral and/or topical 5-ASA, sulfasalazine), “oral steroids” 
(prednisone, systemic steroids), “immunosuppressive drugs” (methotrexate, 
azathioprine, 6-mercaptopurine), and “biologicals” (infliximab, adalimumab, 
certolizumab). Diagnosis and clinical characteristics of the disease were taken from the 
clinical report forms. Duration of disease and patient’s age were treated as continuous 
variables. Disease characteristics were grouped according to the Vienna classification 
(24).  
Statistical analysis 
Univariate analyses were performed using logistic regression to examine the strength of 
the association between compliance to treatment and information seeking, and other 
exposure variables. Odds ratios (OR) and 95% confidence intervals (CI) were 
calculated. Statistical significance of the association between compliance to treatment 
and each factor was assessed using likelihood ratio tests (LRT). To investigate for 
potential confounding of the association between compliance and information seeking, 
factors significantly associated with the outcome (LRT < 0.1) were tested for 
association with the main exposure. Chi-2 test or Fisher’s test were used to test for the 
null hypothesis of no association between variables. A LR test was performed to assess 
for potential interaction between information seeking and drug regimen. The association 
between adherence to treatment and information seeking was then controlled for 
potential confounders using a multivariate logistic regression model. Adjusted OR were 
compared with crude OR for the effect of information seeking on compliance to assess 
for the strength of confounding effect. Other strong risks factors identified in previous 
studies were also controlled for in the final adjusted model. To compare information 
11 
 
seeking sources and themes searched between groups of compliant and non-compliant 
seekers patients, the proportions of those who consulted each of the 6 different sources, 
respectively each of the different topics, were calculated with 95% CI. The differences 
between proportions of those who consulted the source, respectively the theme were 
calculated and a z-test was performed for testing the null hypothesis of no difference. 
Results presented in the tables were converted in percentages. 
Analyses were conducted using STATA statistical software v.12.1 (STATA Corp. 
Texas, USA).  
Ethics approval 
SIBDCS approvals were obtained from the respective regional Swiss Ethics 
Committees where cohort patients were enrolled.   
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RESULTS 
By October 2009, 1530 adult patients were included in the cohort when we started the 
survey. 262 (17.1%) patients had to be excluded due to incomplete baseline 
questionnaires or clinical reports. From the remaining patients, 204 (16.1%) did not take 
any IBD medication and measures of compliance were missing for 122 (11.5%) patients 
who took medication. Out of the 942 drug treated patients, with drug and adherence 
data, 537 (57%) responded to the survey on information seeking. From the 537 
respondents, 25 (4.7%) had to be excluded because their answers were incomplete. The 
number of patients finally analysed in the present study was 512.  
Description of the study population 
Half of the patients were males; the mean age was 41 years, and median disease 
duration 7 years (table 2). Half of the patients were married (N=260), and two-thirds 
(N=339) had a secondary education level. Most patients were working full or part-time 
(62.1%; N=318). About one out of six patients had moderate to severe anxiety (16.2%; 
N=83), and one out of fifteen had severe depression (6.5%; N=33). Eighteen percent 
(N=99) reported to be non-compliant to treatment, and nearly two thirds (N=353) of the 
patients were seeking information on their disease. Half of the patients suffered from 
CD, 65.1% (N=183) of them had colonic affections (Table 3). About one third had a 
fistulizing disease course, which represents the phenotype with the highest burden. Left-
sided disease was the most frequent location in UC. One third of IBD patients (N=154) 
had experienced at least one resection surgery and two-thirds (N=322) >=1 disease-
related complication. One third of patients (N=162) used alternative medicines and 
nearly two-thirds (N=320) used nutritional supplements. Three quarters (N=366) of the 
patients were under immunosuppressive drug or 5-aminosalicylates, and one out of five 
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was under biological therapy. Forty-two percent of the patients under drug therapy took 
at least two concomitant medications. 
Correlates of treatment non-compliance 
The crude odds of being non-adherent (table 4) was significantly higher among 
information seekers (69%, p=0.045), and decreased significantly by 3% with each 
year’s increase of age (p<0.001). No strong evidence of association with non-
compliance was found for duration of disease, gender, marital and working status, 
education level, anxiety and depression scores. Crude odds of being non- compliant 
were 48% lower among patients with a previous history of surgery (p=0.016) or who 
were using nutritional supplements (p=0.005) (table 5). Factors significantly associated 
with non-compliance were considered as potential confounders, after checking 
association between those factors and information seeking. Interaction between 
information seeking and drug regimen was tested; results showed no evidence of an 
interaction between these two variables (LRT p-value=0.884).  
A first model was fitted which included the two confounding factors (nutritional 
supplements use and drug regimen), and known risk factors for compliance (age, history 
of surgery and complications, marital status).  Then, further adjustment was made on 
gender, education level, working status and HADS anxiety and depression scores. This 
choice was made because these were identified as risk factors for the outcome in 
previous studies. The adjusted OR for non-compliance was found to be 2.44 among 
information seekers compared to non-seekers (p=0.003), table 6. There was marginal 
evidence of an association between adherence and the use of nutritional supplements 
(p=0.038). Age, taking antibiotics/topical steroids or 5-ASA compounds remained 
significantly associated with non-compliance. 
14 
 
Analysis of information seeking sources and themes 
Gastroenterologists were the most frequent source of information (N=304; 90.7%), 
followed by the internet (N=250; 74.6%), books or TV (N=143; 42.7%) and family 
doctor (N=130; 38.8%), figure 1. Patients associations were consulted by 62 patients 
(18.5%) and pharmacists by 17 (5.1%). Compliant patients mentioned their general 
practitioner (GP) as a more frequent source of information on IBD than non-compliant 
patients (p=0.019), as were books or TV. No evidence for a difference in the 
frequencies of consultation was observed for sources such as internet, 
gastroenterologists, pharmacists or patients associations. The most frequent information 
topics searched were “therapy” (N=155; 46.3%), “research and development on IBD” 
(N=151; 45.1%), and “tips for daily disease management” (N=123; 36.7%). Basic 
information on the diseases were sought by 17.9% of the patients and 6.9% mentioned 
they sought sharing of experience. Searching for tips for daily disease management was 
14.2% higher in the group of patients non- compliant to treatment compared to the 
group of patients who were compliant. There was no evidence of a difference among 
groups for information concerns on research and development on IBD, therapies, basic 
information on the disease, patients experience sharing or miscellaneous information for 
non-adherent compared to compliant patients.   
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DISCUSSION 
Nearly one out of five patients was non-compliant to drug treatment and 69% of 
patients were actively seeking information on their disease. We found that non- 
compliant patients were 2.44 times more likely to be active information seekers as 
compared to non-seekers after controlling for confounders and known risks factors for 
non-compliance. Patients who were compliant to drug treatments mentioned general 
practitioners to be a source of information significantly more often than non-compliant. 
They searched 13.1% more often information from books or TV. Information topics 
linked to tips for disease management were significantly of more interest among non-
compliant patients compared to those who were compliant.  
 
The majority of patients’ compliant to their drug treatments did not search for additional 
information, which may be interpreted as an overall satisfaction, in terms of information 
needs. Alternatively, some patients may be compliant to treatment without asking 
detailed information about treatment rationale, expected benefits and possible adverse 
events. Secondly, we observed that overall information seeking was strongly associated 
with non-compliance to treatment. Although the design of our study does not allow 
conclusions on the cause of this association, this may indicate that non-compliant 
patients have different needs in terms of information on their disease compared to 
compliant patients. Information seeking therefore is an important issue to consider. In 
other chronic diseases such as cancer, studies have shown that patients searching for 
health-related information were more compliant (25-27). This was not confirmed in the 
present study with IBD patients; this may have been partly influenced by the specific 
conditions and course of IBD; indeed mortality rates due to IBD are low (8/10,000) 
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compared to those observed for cancers and the overall symptomatology is different in 
inflammatory compared to non-inflammatory chronic diseases. A recent study of 
Borgaonkar et al. showed that disease-related information seeking had a negative effect 
on quality of life in IBD (28). Our findings showed that this effect should probably be 
modulated according to information concerns. Indeed, information topics linked to 
symptoms and disease management were a major concern for non-compliant patients; 
information on therapies was an important, but similar, concern for both compliant and 
non-compliant patients.  
The internet was a major a source of information used by three quarters of the study 
population, but not more frequently by non-compliant compared to compliant patients. 
This confirms the frequent use of internet, despite known problems with the quality of 
information provided, as recently shown (29-31). The fact that books or TV were 
frequently mentioned, especially among compliant patients, shows that these were still 
considered as a valued source of information for patients. Apart from 
gastroenterologists, the most frequent source of information, general practitioners were 
also frequently asked about IBD. Our results indicate that there might be a need for 
improving communication between doctors and patients, and so between 
gastroenterologists and patients, at least in Switzerland. If patients seek for information, 
they need to find answers, not only in terms of risks, benefits of taking their therapies 
regularly, but also concerning symptoms and everyday disease management. Findings 
may suggest that the time doctors take to discuss tips for daily disease management 
should be considered as a central point. Kane (6) suggests that dialogues with patients 
during medical visits could be seen as too time-consuming for the physician, but are 
important in terms of explaining in an appropriate manner to the patient issues 
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concerning, for example, drug information. Physicians should not overestimate the level 
of knowledge of patients neither on drugs instructions, nor on the disease itself (32, 33). 
Actual time available for information activity is probably differently shared by a general 
practitioner compared to a gastroenterologist, who needs to perform technical acts more 
often. Results tend however to suggest and appeal for an increased integrative 
healthcare approach for IBD patients, including physicians from different specialties, 
but also pharmacists, or IBD nurses which do currently not exist in Switzerland.  
 
The innovative character of this study is the use of clinical and patient data from an 
already established national clinical cohort, with patients enrolled throughout the 
country and followed in diverse settings. This allowed us to capture a picture regarding 
compliance to treatment and information concerns at a national level, which is 
important regarding future communication issues. The use of open questions to gather 
information on themes searched was another strength of the study as this allowed 
exploring answers in a way which has not been previously done. Information on 
compliance to treatments is generally not easy to collect, as shown previously (6, 19, 
34). In the SIBDC, we decided to collect compliance to treatment via self-reported 
patient questionnaires using a local scale, not the standard validated ones used to 
measure adherence. We understand this may be a limitation of our study.  Although 
compliance was measured using closed questions, we could not avoid potential recall 
bias from patients that may have reported compliance. One more objective measure of 
treatment compliance could be made for example, through serum drug levels; this 
would however not be possible for all treatments. A combination of methods to gather 
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information on compliance would probably be a future possibility to consider for 
patients with multiple and complex therapy options like those with IBD.  
In comparison to other studies, Swiss IBD patients reported a lower proportion of non-
compliance. This may be due to various reasons. Cultural factors may explain the fact 
that patients from the study population might fear communicating that they did not 
adhere to their drug regimens, compared to other populations (10) (35). Another reason 
may be related to the fact that in Switzerland, the number of patients under biological 
treatments, especially infliximab, is higher than in other countries. Compliance to 
infliximab should be measured in a different way, as patients need to come for 
intravenous administration, which is more controlled by the doctors and cannot be 
avoided, except by not coming to the medical visit (16). We consider information 
seeking as the overall searching activity spanning different phases of disease activity or 
remission. It could be argued that this may lead to information bias because patients 
may be reporting active information seeking in acute phases only, although being in 
remission for a long time, as mentioned in the patient charts. However, this may be 
compensated by the fact that overall perception related to the disease was shown to 
potentially differ between patients and gastroenterologists (32). Indeed, flares and acute 
symptoms linked to disease activity may be experienced by the patients more often than 
actually declared to the physician, mainly because concerns linked to one’s own disease 
management differs from that seen through the doctor’s eyes. Patients obviously 
accommodate to their disease over time. We can thus be confident that the way we have 
taken into account overall information seeking would not lead to strong 
misclassification.  
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Selection bias might have occurred due to the high number of non-respondents to the 
information questionnaire. We investigated therefore the characteristics between both 
groups with respect to main exposure and risk factors. This showed that non-respondent 
were somewhat less educated and more often full-time workers, unemployed or retired 
than responders. They were also slightly more anxious or depressive. Therefore, one 
might argue that this may affect generalisability of the findings. 
In this study, we took into account risks factors that were reported in previous studies. 
Obviously, there might be some other confounders, known or unknown, which should 
be taken into account. For example, patient perception of the benefits and risks linked to 
the drug should also be taken into account because this may differ considerably between 
subjects. 
 
In conclusion, there is a need to better understand patient beliefs and attitudes, both 
towards disease and drugs. Better information and communication should be the first 
step towards improved compliance to treatment and, eventually, better outcomes. 
Further investigations should be done to confirm these observations. Combining 
quantitative and qualitative approaches might allow deeper exploration about where 
deficit of information might be and the potential consequences on treatment compliance. 
Nevertheless, a take home message for gastroenterologists might be to ask patients 
explicitly about their information needs and concerns, either directly or with the 
collaboration of a nurse or through other tools accessible for the patient, e.g., in the 
waiting room.    
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TABLES 
 
Table 1: Details of sub-themes and main themes of information searched 
 
Main themes Sub-themes 
Research and development on IBD Clinical trials 
Origins of the disease 
Hereditary, genetic factors 
Trends in mortality and morbidity 
Epidemiological results / comparison with other 
countries 
Can we cure the disease? 
Research and development on the disease 
Research and development on new drugs and therapies 
Therapies Comparison between treatments 
Adverse events of drug treatments 
Information on biological treatments 
Information on steroids 
Consequences of stopping / changing drug treatments 
Information on drug medication or other therapies 
Information on surgeries 
Alternative treatments 
Supplementation medicines 
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Tips for daily disease management Nutrition 
How to speak to children with the disease 
Risk factors for recurrence of symptoms 
How to prevent recurrence of symptoms? 
Consequences on lifestyle 
Do psychosomatic factors influence the disease? 
Gynaecological aspects 
Pregnancy and babies 
Employment rights and professional activity 
Quality of life 
How to accept the disease status 
Patients experience sharing Exchanges / experiences sharing 
Positive experiences with the disease 
Patients support groups 
TV reports, patients stories, testimonies 
Basic information on the disease All about the disease 
Information on chronic diseases 
Information on complications 
Information on vaccines 
Information on the disease 
Information on gastroenterology 
Cancer 
Miscellaneous Popular information  
Updated information 
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Information for Swiss people 
Information for younger/older 
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Table 2: Socio-demographic and psychosocial characteristics of the study population. 
Values are numbers (percentages) unless stated otherwise 
 
Variable Total Compliant Non-compliant
All patients 512 (100.0) 413 (80.7) 99 (19.3) 
Age (years) 41 (14) # 43 (14)# 36 (13)# 
Duration of disease (years) 7 (12.5) $ 7 (13)$ 7 (10)$ 
Information seeking    
 No 159 (31.1) 138 (33.4) 21 (21.2) 
 Yes 353 (68.9) 275 (66.6) 78 (78.8) 
Gender    
 Men 248 (48.4) 198 (47.9) 50 (50.5) 
 Women 264 (51.6) 215 (52.1) 49 (49.5) 
Marital status    
 Not married 252 (49.2) 195 (47.2) 57 (57.6) 
 Married 260 (50.8) 218 (52.8) 42 (42.4) 
Education level    
 Primary (mandatory) education level 57 (11.1) 49 (11.9) 8 (8.1) 
 Secondary education level 339 (66.2) 269 (65.1) 70 (70.7) 
 University level 112 (21.9) 92 (22.3) 20 (20.2) 
 Missing value 4 (0.8) 3 (0.7) 1 (1.0) 
Working status    
 Full-time 197 (38.5) 157 (38.0) 40 (40.4) 
 Part-time 121 (23.6) 97 (23.5) 24 (24.2) 
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 Unemployed 12 (2.3) 9 (2.2) 3 (3.0) 
 In training 60 (11.7) 46 (11.1) 14 (14.1) 
 At home 37 (7.2) 28 (6.8) 8 (9.1) 
 Retired 78 (15.2) 71 (17.2) 7 (7.1) 
 Missing value 7 (1.4) 5 (1.2) 2 (2.0) 
HADS Anxiety    
 Normal 311 (60.7) 248 (60.1) 63 (63.6) 
 Mild 104 (20.3) 87 (21.1) 17 (17.2) 
 Moderate 65 (12.7) 51 (12.4) 14 (14.1) 
 Severe 18 (3.5) 17 (4.1) 1 (1.0) 
 Missing value 14 (2.7) 10 (2.4) 4 (4.0) 
HADS Depression    
 Normal 404 (78.9) 322 (78.0) 82 (82.8) 
 Mild 63 (12.3) 55 (13.3) 8 (8.1) 
 Moderate 29 (5.7) 25 (6.1) 4 (4.0) 
 Severe 4 (0.8) 3 (0.7) 1 (1.0) 
 Missing value 12 (2.3) 8 (1.9) 4 (4.0) 
 
# Mean and standard deviation (SD) 
$ Median and inter-quartile range (IQR) 
  
 
  
31 
 
Table 3: Disease- and drug-related characteristics of the study population. Values are 
numbers (percentages) unless stated otherwise 
 
Variable Total Compliant Non-compliant 
All patients 512 (100.0) 413 (80.7) 99 (19.3) 
Diagnosis    
 Crohn’s disease (CD) 281 (54.9) 235 (56.9) 46 (46.5) 
 Ulcerative colitis (UC) 231 (45.1) 178 (43.1) 53 (53.5) 
Disease location (UC only)    
 Proctitis 32 (13.8) 20 (11.2) 12 (22.6) 
 Left-sided 108 (46.8) 86 (48.3) 22 (41.5) 
 Pancolitis 85 (36.8) 67 (37.6) 18 (34.0) 
 Unknown 6 (2.6) 5 (2.8) 1 (1.9) 
Disease location (CD only)    
 Ileal only 67 (23.8) 52 (22.1) 15 (32.6) 
 Colic only  95 (33.8) 82 (34.9) 13 (28.3) 
 Ileo-colic 88 (31.3) 75 (31.9) 13 (28.3) 
 Upper GI 18 (6.4) 16 (6.8) 2 (4.4) 
 Unknown 13 (4.6) 10 (4.3) 3 (6.5) 
Phenotype (CD only)    
 Inflammatory 138 (49.1) 107 (45.5) 31 (67.4) 
 Stenotic 54 (19.2) 47 (20.0) 7 (15.2) 
 Fistulizing 89 (31.7) 81 (34.5) 8 (17.4) 
Previous surgeries    
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 None 358 (69.9) 279 (77.9) 79 (22.1) 
 Yes (≥1) 154 (30.1) 134 (87.0) 20 (13.0) 
Previous complications    
 None 190 (37.1) 144 (34.9) 46 (46.5) 
 Yes (≥1) 322 (62.9) 269 (65.1) 53 (53.5) 
Alternative medicine use    
 None 350 (68.4) 278 (67.3) 72 (72.7) 
 Yes (≥1) 162 (31.6) 135 (32.7) 27 (27.3) 
Nutritional supplements    
 None 192 (37.5) 142 (34.4) 50 (50.5) 
 Yes (≥1) 320 (62.5) 271 (65.6) 49 (49.5) 
Drug regimen    
 Antibiotics or topical steroids 8 (1.6) 5 (1.2) 3 (3.3) 
 5-ASA 120 (23.4) 82 (19.9) 38 (38.4) 
 Oral steroids  33 (6.5) 25 (6.1) 8 (8.1) 
 Immunosuppressive drugs 246 (48.0) 207 (50.1) 39 (39.4) 
 Biologicals 105 (20.5) 94 (22.8) 11 (11.1) 
Number of drugs    
 1 299 (58.4) 241 (58.4) 58 (58.6) 
 2 139 (27.1) 111 (26.9) 28 (28.3) 
 3 53 (10.4) 43 (10.4) 10 (10.1) 
 >3 21 (4.1) 18 (4.4) 3 (3.0) 
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Table 4: Crude OR and 95% CI for non-compliance according to socio-demographic 
risk factors 
 
Variable Crude OR 
(95%CI) 
LR test P-value 
All patients   
Information seeking   
 No 1.00  
 Yes 1.69 (0.99 – 2.87) 0.045 
Age (years) 0.97 (0.95 – 0.98) <0.001* 
Duration of disease (years) 0.98 (0.96 – 1.01) 0.282 
Gender   
 Men 1.00  
 Women 0.95 (0.60 – 1.50) 0.827 
Marital status   
 Not married 1.00  
 Married 0.68 (0.43 – 1.08) 0.098 
Education level   
 Primary education level 1.00  
 Secondary education level 0.35 (0.15 – 0.85)  
 University level 0.45 (0.18 – 1.08) 0.218 
Working status   
 Full-time 1.00  
 Part-time 0.95 (0.53 – 1.70)  
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 Unemployed 1.35 (0.35 – 5.23)  
 In training 1.29 (0.64 – 2.59)  
 At home 1.35 (0.56 – 3.24)  
 retired 0.40 (0.17 – 0.94) 0.154 
HADS Anxiety   
 Normal 1.00  
 Mild 0.79 (0.44 – 1.43)  
 Moderate 1.09 (0.55 – 2.13)  
 Severe 0.24 (0.03 – 1.81) 0.312 
HADS Depression   
 Normal 1.00  
 Mild 0.60 (0.28 – 1.32)  
 Moderate 0.64 (0.21 –  1.88)  
 Severe 1.33 (0.14 – 12.95) 0.490 
 
* P-value for linear trend. Test for departure from linear trend comparing model with 
age as continuous variable with quartile categories of age showed LRT P-value = 0.868. 
Therefore, age was considered as a continuous variable. 
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Table 5: Crude OR and 95% CI for non-compliance according to disease- and drug-
related risk factors 
Variable Crude OR 
(95%CI) 
LR test P-value 
All patients   
Diagnosis   
 Crohn’s disease 1.00  
 Ulcerative colitis 1.41 (0.89 – 2.22) 0.138 
Disease location (UC only)   
 Proctitis 2.83 (1.18 – 6.82)  
 Left-sided 1.00  
 Pancolitis 1.27 (0.61 – 2.62) 0.072 
Disease location (CD only)   
 Ileal only 1.00  
 Colic only  0.59 (0.25 – 1.40)  
 Ileo-colic 0.68 (0.29 – 1.58)  
 Upper GI 0.46 (0.09 – 2.27) 0.597 
Phenotype (CD only)   
 Inflammatory 1.00  
 Stenotic 0.49 (0.21 – 1.12)  
 Fistulizing 0.36 (0.17 – 0.78) 0.006 
Previous surgeries   
 None 1.00  
 Yes (≥1) 0.52 (0.30 – 0.91) 0.016 
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Previous complications   
 None 1.00  
 Yes (≥1) 0.64 (0.41 – 1.02) 0.061 
Alternative medicine use   
 None 1.00  
 Yes (≥1) 0.71 (0.43 – 1.19) 0.188 
Nutritional supplements   
 None 1.00  
 Yes (≥1) 0.52 (0.33 – 0.83) 0.005 
Drug regimen   
 Antibiotics or topical steroids 5.22 (1.08-25.19)  
 5-ASA 3.87 (1.80 – 8.29)  
 Oral steroids  2.44 (0.84 – 7.05)  
 Immunosuppressive drugs 1.58 (0.75 – 3.33)  
 Biologicals 1.00 0.001 
Number of drugs   
 1 1.00  
 2 0.96 (0.57 – 1.63)  
 3 0.99 (0.47 – 2.10)  
 >3 0.49 (0.11 – 2.18) 0.790 
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Table 6: Odds ratio and 95% CI for non-compliance and information seeking, adjusted 
for confounding factors and other selected risk factors 
 
Variable Adjusted OR* 
95%CI 
Adjusted OR# 
95%CI 
Information seeking   
 No 1.00 1.00 
 Yes 2.02 (1.15 – 3.57) 2.43 (1.34 – 4.41) 
Age (years) 0.96 (0.94 – 0.98) 0.96 (0.94 – 0.99) 
Marital status   
 Not married 1.00 1.00 
 Married 0.77 (0.44 – 1.34) 0.67 (0.37 – 1.22) 
Previous surgeries   
 None 1.00 1.00 
 Yes (≥1) 0.79 (0.43 – 1.46) 0.80 (0.43 – 1.50) 
Previous complications   
 None 1.00 1.00 
 Yes (≥1) 0.91 (0.55 – 1.51) 0.92 (0.54 – 1.55) 
Nutritional supplements   
 None 1.00 1.00 
 Yes (≥1) 0.61 (0.38 – 1.02) 0.57 (0.34 – 0.97) 
Drug regimen   
 Antibiotics or topical 
steroids 
11.31 (2.06 – 62.11) 13.53 (2.31 – 79.02) 
38 
 
 5-ASA 4.94 (2.15 – 11.39) 5.27 (2.23 – 12.48) 
 Oral steroids  2.99 (0.98 – 9.10) 3.28 (1.04 – 10.30) 
 Immunosuppressive drugs 1.96 (0.91 – 4.23) 1.91 (0.87 – 4.17) 
 Biologicals 1.00 1.00 
*Model 1: adjusted for age, nutritional supplements, marital status, history of surgery, 
history of complications and drug regimen. #Model 2: additionally adjusted for gender, 
education level, working status and HADS scores. 
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FIGURE 
 
Figure 1: Comparison of (A) sources and (B) themes of information consulted among 
patients compliant and non-compliant to treatment.  
 
 
